Market Cap (In CNY)
11.3 Billion
Revenue (In CNY)
5.34 Billion
Net Income (In CNY)
612.46 Million
Avg. Volume
2.48 Million
- Currency
- CNY
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 13.01-23.09
- PE
- -
- EPS
- -
- Beta Value
- 0.416
- ISIN
- CNE100004NS2
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Mr. Yuda Gong
- Employee Count
- -
- Website
- https://www.gbgcn.com
- Ipo Date
- 2021-08-02
- Details
- Guobang Pharma Ltd. engages in the research and development, production, and sale of medical products for human and animals in China. It offers medical products, including APIs, medication intermediates related to the API, and formulations; and veterinary products, such as APIs for animals, additives, and formulations. The company was founded in 1996 and is based in Xinchang, China.
More Stocks
-
600063
-
BLBLFBilibili Inc.
BLBLF
-
ENGNW
-
5106
-
7350
-
0104
-
ASHOKREAshoka Refineries Limited
ASHOKRE
-
DAULATDaulat Securities Limited
DAULAT